MedTech News
.................... by Andrew Celentano
Immune navigation system discovery could lead to better treatments for chronic inflammation
A scientific collaboration between the University of Bath (UK) and the UMass Chan Medical School (U.S.) has determined how a specific type of white blood cell—neutrophils—moves through the body.
Total Flow Medical earns FDA nod for femoral arterial cannula for cardiopulmonary bypass
Total Flow Medical announced today that it received FDA 510(k) clearance for its TFA femoral arterial cannula device.
MMI gets FDA green light to expand study of surgical robot in Alzheimer’s
Medical Microinstruments (MMI) announced today that the FDA approved a supplement to a study of its surgical robot in Alzheimer’s.
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
PITTSBURGH, July 29, 2026 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved Gwyn Lo™ (norelgestromin and ethinyl estradiol transdermal system). Gwyn Lo is a new combined hormonal contraceptive (CHC) patch with low-dose estrogen. The patch has demonstrated contraceptive efficacy for women of childbearing potential with a body mass index (BMI) below 30 kg/m² who are appropriate candidates for CHC. The Gwyn Lo dosage is norelgestromin 220 mcg/day and ethinyl estradiol 20 mcg/day.
RWJBarnabas Health and Rutgers Researchers Find AI Tool Helps Detect Patient Deterioration Earlier, Reducing Hospital Deaths
WEST ORANGE, N.J., July 29, 2026 /PRNewswire/ — Researchers from RWJBarnabas Health and Rutgers Robert Wood Johnson Medical School found that an artificial intelligence (AI)-enabled early warning system helped identify hospitalized patients at risk of rapid clinical decline sooner, contributing to fewer deaths among high-risk patients.
Gene editing tool reduces Huntington’s toxic protein fragments and symptoms in mice
A gene-editing tool designed to precisely rewrite the gene that causes Huntington’s disease reduced toxic protein fragments and symptoms associated with the disease in mice, researchers at the University of Illinois Urbana-Champaign report.
New mechanism reveals how heart cells resist regenerative reprogramming
Specialized cells in the human body make biological trade-offs to perform certain jobs. Because the adult human heart cannot repair itself the way skin does, scientists have studied ways to “reprogram” heart cells to regenerate after heart attacks.
Scientists develop microRNA-based gene therapy that halts ALS progression in mice
A single IV injection of a microRNA-based biologic developed by Guangping Gao, Ph.D., Robert H. Brown Jr., DPhil, MD, Jun Xie, Ph.D., and Zuoshang Xu, MD, Ph.D., suppressed production of the mutant SOD1 protein that causes amyotrophic lateral sclerosis (ALS), delayed disease onset by 60 days and extended lifespan by 100 days—more than tripling the average survival time—in mouse models of the disease.